Recurrent BRCA2 exon 3 deletion in Assyrian families.
Rachel HodanKerry KinghamAllison W KurianPublished in: Journal of medical genetics (2023)
We identified six patients from five families with a recurrent mutation: NM_000059.3 ( BRCA2 ) exon 3 deletion. All families self-identified as Assyrian. Assyrians are an ethnoreligious population of ancient Mesopotamia, now mostly living in modern day Iraq, Syria, Turkey and Iran. They are historically a socially isolated population with intermarriage within their community, living as a religious and language minority in mostly Muslim countries. The probands of each family presented with a classic BRCA2- associated cancer including early-onset breast cancer, epithelial serous ovarian cancer, male breast cancer and/or high-grade prostate cancer, and family history that was also significant for BRCA2 -associated cancer. BRCA2 exon 3 deletion is classified as pathogenic and has been previously described in the literature, but it has not been described as a founder mutation in a particular population. We characterise this recurrent BRCA2 pathogenic variant in five Assyrian families in a single centre cohort.
Keyphrases
- breast cancer risk
- high grade
- early onset
- prostate cancer
- papillary thyroid
- healthcare
- ejection fraction
- end stage renal disease
- systematic review
- late onset
- autism spectrum disorder
- squamous cell
- low grade
- newly diagnosed
- mental health
- squamous cell carcinoma
- prognostic factors
- patient reported outcomes
- lymph node metastasis
- patient reported